Navigation Links
BGI and ACRG announce collaboration to accelerate cancer research in Asia

Shenzhen, China - BGI, the world's largest genomics organization and Asia Cancer Research Group (ACRG), a not-for-profit organization established to accelerate research and ultimately improve treatment for patients affected with the most commonly-diagnosed cancers in Asia, jointly announced a new collaboration on cancer genomics research as part of ACRG's mission to generate a unique and best-in-class data source on cancers prevalent in Asia, and to accelerate research and development of improved treatments for those cancers by freely sharing the resulting data with the scientific community.

The two parties will work together to conduct genomic research on lung cancer and liver cancer, two of the most common cancers in Asia. Lung cancer is one of the most common cancers for males and causes about 1.3 million deaths globally per year. The incidence of lung cancer has risen dramatically for both males and females in Asia in past decades. Liver cancer is the sixth most commonly diagnosed cancer and the third leading cause of cancer death. Hepatocellular carcinoma (HCC), the most common type of liver cancer, causes nearly 700,000 deaths worldwide annually, half of which occur in China.

BGI and ACRG will conduct the lung and liver cancer studies at the genomic level. ACRG will provide samples of lung and liver cancer tissues, and BGI will sequence these samples on its large-scale next-generation sequencing platforms, produce high-quality data output and provide bioinformatics analysis.

"The collaboration will accelerate the establishment of a pharmacogenomic database for Asian lung and liver cancers," said Dr. Mao Mao, President of ACRG. "Through this collaboration and the subsequent sharing of information with the broader scientific community, we are hoping to increase our knowledge of these two common cancers in Asia, and to accelerate the development of new diagnostic methods and therapies."

"We are very excited about this new partnership with ACRG. Given BGI's expertise in genomics research and ACRG's advances in cancer studies, I believe this partnership will accelerate cancer research, from understanding the basic mechanism to developing effective treatments for cancer," said Professor Huanming Yang, Chairman of BGI. "It's our first time applying comprehensive solutions to cancer research, and we believe the study will bring new perspectives for researchers that could facilitate biotechnology and pharmaceutical research in the future." he added.

Contact: Jia Liu
BGI Shenzhen

Related biology news :

1. A major prize in the chemical sciences announced by the Camille and Henry Dreyfus Foundation
2. 2008 SNM Wagner-Torizuka Fellowships announced
3. NIAID announces 25 new awards to develop radiation countermeasures
4. Aware Announces Q3 2008 Earnings Conference Call
5. Governor Doyle announces historic genomic research collaboration
6. BIO-key(R) Announces Additional $245,000 in Third Quarter Public Safety Orders
7. San Diego Supercomputer Center and UCSD announce Triton Resource
8. NARSAD announces 2008 Prizes for Outstanding Achievement in Research on Mental Health Disorders
9. GUMC and Oak Ridge National Labs announce unique research partnership
10. Parkinsons Disease Foundation announces award of $150,000
11. Jefferson Department of Surgery announces new pancreas tumor registry
Post Your Comments:
(Date:5/16/2016)... --  EyeLock LLC , a market leader of iris-based ... IoT Center of Excellence in Austin, Texas ... embedded iris biometric applications. EyeLock,s iris authentication ... with unmatched biometric accuracy, making it the most proven ... platform uses video technology to deliver a fast and ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... of Infosys (NYSE: INFY ), and Samsung SDS, ... partnership that will provide end customers with a more ... payment services.      (Logo: ) ... financial services, but it also plays a fundamental part in ...
(Date:4/19/2016)... April 20, 2016 The new ... a compact web-based "all-in-one" system solution for all door ... reader or the door interface with integration authorization management ... control systems. The minimal dimensions of the access control ... the building installations offer considerable freedom of design with ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... ... Amgen, will join the faculty of the University of North Carolina Kenan-Flagler ... of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on the school’s ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... ... June 23, 2016 , ... UAS LifeSciences, one of ... their brand, UP4™ Probiotics, into Target stores nationwide. The company, which has been ... Target to its list of well-respected retailers. This list includes such fine stores ...
(Date:6/23/2016)... 23, 2016 Houston Methodist Willowbrook Hospital ... Sports Association to serve as their official health ... Methodist Willowbrook will provide sponsorship support, athletic training ... association coaches, volunteers, athletes and families. ... Sports Association and to bring Houston Methodist quality ...
Breaking Biology Technology: